Cardiff Oncology (CRDF) Other Accumulated Expenses (2020 - 2026)

Cardiff Oncology has reported Other Accumulated Expenses for 6 years, with the latest figure at $287000.0 in Q4 2025.

• Quarterly Other Accumulated Expenses rose 24.78% year-over-year to $287000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $287000.0 (up 24.78% YoY) and the FY2025 annual result came in at $287000.0, up 24.78% from the prior year.
• Other Accumulated Expenses grew to $287000.0 in Q4 2025 per CRDF's latest filing, from $228000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $419000.0 in Q1 2025 and troughed at $8000.0 in Q3 2022.
• A 5-year average of $156461.5 and a median of $203000.0 in 2025 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses tumbled 80.95% in 2022, then advanced 24.78% in 2025.
• Over 5 years, Other Accumulated Expenses stood at $42000.0 in 2021, then sank by 80.95% to $8000.0 in 2022, then jumped by 2487.5% to $207000.0 in 2023, then rose by 11.11% to $230000.0 in 2024, then grew by 24.78% to $287000.0 in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $287000.0, $228000.0, and $203000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.